• Catalog Number:

  E1A1024A-3

• Amount:

  100ul

• Form of Antibody:

  Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.

• Storage/Stability:

  Store at -20℃/1 year

• class="eg_cn_title"Immunogen:

  The antiserum was produced against synthesized phosphopeptide derived from human Calsenilin/KCNIP3 around the phosphorylation site of serine 63 (D-S-SP-D-S).

• Purification:

  The antibody was affinity-purified fromrabbit antiserum by affinity-chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.

• Reactivity:

  Human, Mouse

• SwissProtNo:

  Q9Y2W7

• Applications:

  WB: 1:500~1:1000 IHC: 1:50~1:100 IF: 1:100~1:500 ELISA: 1:20000

• Other Names:

  A-type potassium channel modulatory protein 3, CSEN, DRE-antagonist modulator, DREAM, KCNIP3, KChIP3, Kv channel-interacting protein 3

• Specificity Sensitivity:

  Calsenilin/KCNIP3 (Phospho-Ser63) antibody detects endogenous levels of Calsenilin/KCNIP3 only when phosphorylated at serine 63.

• References:

  Terman B.I., Oncogene 6:1677-1683(1991). Mitola S., J. Virol. 74:344-353(2000). Sjoeblom T., Science 314:268-274(2006).

• All Sites:

  Human: Ser63; Mouse: Ser63

P-peptide - +

Immunohistochemistry analysis of paraffin-embedded human brain tissue using Calsenilin/KCNIP3 (Phospho-Ser63) antibody. Western blot analysis of extracts from 293 cells treated with PMA (125ng/ml, 30mins) and Jurkat cells treated with forskolin (40nM, 30mins) , using Calsenilin/KCNIP3 (Phospho-Ser63) antibody.

P-peptide - + Immunofluorescence analysis of HeLa cells, using Calsenilin/KCNIP3 (Phospho-Ser63) antibody.